Alma Appoints Eyal Ben David as CEO

Alma has appointed Eyal Ben David as Chief Executive Officer, as part of a wider leadership transition approved by the board of Sisram Medical, Alma’s parent company. Under the changes, Lior Dayan will move from CEO into the role of Chairman of Sisram Medical, while Ben David takes over day to day leadership at Alma.

Ben David is a 16 year Alma veteran and most recently served as President of International Markets, with the company citing his role in shaping strategy and rolling out its direct approach commercial model across key markets. The group also confirmed that Sisram CFO Jiahong Li will expand his responsibilities as Alma’s Co CEO.

Sisram Chairman Liu Yi said, “Lior Dayan has been an exceptional leader and visionary. He transformed the company into a category-defining global brand and built the foundation for long-term strategic expansion. As Chairman of Sisram, his insight and experience will be invaluable as we continue to execute our global strategy.”

Dayan added, “Leading Alma’s transformation has been one of the most rewarding experiences of my career. I have full confidence that under Eyal’s and Jiahong’s leadership, the company will continue to expand its global impact, pioneer new technologies, and shape the future of medical aesthetics. As Chairman, I look forward to supporting and guiding this exceptional leadership team as it leads Alma into its next chapter of growth.”

Alongside the Alma and Sisram changes, the group said Keith Adams, currently President of Alma Inc., will transition into the role of Chairman of Alma Inc. and Senior Vice President of Sisram’s Corporate Development, with Spencer Detter, currently Vice President of Sales, stepping into the role of Acting General Manager.